Estramustine

Dose compliance of estramustine phosphate in neoadjuvant chemohormonal therapy combined with degarelix acetate predicts the biochemical recurrence in patients with very high‐risk prostate cancer who underwent robot‐assisted radical prostatectomy

Takanari Kambe, Toshinari Yamasaki, Akihiro Yamamoto, Akihiko Nagoshi, Tasuku Fujiwara, Yuta Mine, Hiroki Hagimoto, Atsushi Igarashi, Hidetoshi Kokubun, Shiori Murata, Naoki Akagi, Yuto Hattori, Yohei Abe, Naofumi Tsutsumi, Noboru Shibasaki, Mutsushi Kawakita

Citations: 4 • 2024

Impact of Neoadjuvant Chemohormonal Therapy With GnRH Antagonist and Low‐Dose Estramustine in Very High‐Risk Prostate Cancer Undergoing Robotic Radical Prostatectomy

Takanari Kambe, Masashi Kubota, Toshinari Yamasaki, Mutsushi Kawakita, Shiori Murata, Yuto Hattori, Yoichiro Tohi, Yuya Sekine, Ryoma Kurahashi, Kimihiro Shimatani, Atsuro Sawada, Hiromitsu Negoro, Ryoichi Saito, Takayuki Goto, Takashi Kobayashi

Citations: 2 • 2025